From Medscape Oncology

Coverage from the

Society of Gynecologic Oncology Annual Meeting on Women’s Cancers (SGO) 2023

March 25 - 28, 2023; Tampa, Florida and Virtual/Online

March 25 - 28, 2023 Tampa, Florida and Virtual/Online

SGO 2023 Ocular Toxicity With New Drugs for Gynecologic Cancers Antibody-drug conjugates are a promising new option for gynecologic cancers, but they have a variety of ocular or vision-related adverse events that need to be appropriately monitored and managed.
Medscape Medical News, April 3, 2023
SGO 2023 Mirvetuximab: Practice Changing for Some Ovarian Cancers Response rates were superior to those seen with other single agents in patients with platinum-resistant disease and tumors positive for folate receptor alpha.
Medscape Medical News, March 30, 2023
SGO 2023 New Role for Olaparib in BRCA Ovarian Cancer in Neoadjuvant Setting Administering olaparib in the neoadjuvant setting resulted in favorable surgical options, manageable adverse events, and positive health outcomes in women with ovarian cancer and germline mutations.
Medscape Medical News, March 30, 2023

Conference News

SGO 2023 Insurers Refusing MRI for Women at High Risk for Breast Cancer
Medscape Medical News, April 13, 2023
SGO 2023 Ocular Toxicity With New Drugs for Gynecologic Cancers
Medscape Medical News, April 3, 2023
SGO 2023 Mirvetuximab: Practice Changing for Some Ovarian Cancers
Medscape Medical News, March 30, 2023

SGO 2023 New Role for Olaparib in BRCA Ovarian Cancer in Neoadjuvant Setting
Medscape Medical News, March 30, 2023
SGO 2023 No Survival Benefit to Radiation Add-on in Endometrial Cancer
Medscape Medical News, March 29, 2023
SGO 2023 'Home Run': Immunotherapy Add-on for Advanced Endometrial Cancer
Medscape Medical News, March 28, 2023

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

Ovarian Cancer: Key Abstracts From SGO 2023
Shannon N. Westin, MD, MPH
Endometrial Cancer: Key Abstracts From SGO 2023
Shannon N. Westin, MD, MPH

Popular News from Previous SGO Meetings

Water-Only Fasting May Reduce Chemo Modifications Patients with gynecologic malignancies who consumed only water for 24 hours before and after each chemo cycle had fewer dose delays and reductions compared with patients who didn't fast, a small study showed.
Medscape Medical News, Apr 08, 2020
Younger Gynecologic Cancer Patients at Risk for Early Bone Loss These patients should be screened for bone changes, investigators advise.
Medscape Medical News, Apr 02, 2020
Weight Loss Intervention Fails in Endometrial Cancer Survivors Almost half of obese endometrial cancer survivors in a recent study gained weight during 12 months of follow-up, whether or not they participated in a behavioral weight loss intervention.
Medscape Medical News, Apr 08, 2020